Daniela Hernandez, Fusion:
He was closer than he thought. Sitting in the audience that day was Mike O’Reilly, a newly minted vice president for medical technologies at Apple. A few months earlier, Apple had poached O’Reilly from Masimo, a Bay Area-based sensor company that developed portable iPhone-compatible health trackers. Now, he was interested in building something else, something that had the potential to implement Friend’s vision of a patient-centered, medical research utopia and radically change the way clinical studies were done.
After Friend’s talk, O’Reilly approached the doctor, and, in typical tight-lipped Apple fashion, said: “I can’t tell you where I work, and I can’t tell you what I do, but I need to talk to you,” Friend recalls. Friend was intrigued, and agreed to meet for coffee.